Total Payments
$613,066
2024 Payments
$90,387
Companies
36
Transactions
843
Medicare Patients
1,167
Medicare Billing
$105,932
Payment Breakdown by Category
Other$429,449 (70.0%)
Consulting$100,083 (16.3%)
Travel$59,185 (9.7%)
Food & Beverage$17,584 (2.9%)
Research$6,477 (1.1%)
Education$287.31 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $415,999 | 138 | 67.9% |
| Consulting Fee | $100,083 | 36 | 16.3% |
| Travel and Lodging | $59,185 | 129 | 9.7% |
| Food and Beverage | $17,584 | 512 | 2.9% |
| Honoraria | $13,450 | 6 | 2.2% |
| Unspecified | $6,477 | 17 | 1.1% |
| Education | $287.31 | 5 | 0.0% |
Payments by Type
General
$606,589
826 transactions
Research
$6,477
17 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $213,818 | 247 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $106,583 | 84 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $89,942 | 145 | $0 (2024) |
| GENZYME CORPORATION | $78,685 | 62 | $0 (2024) |
| Optinose US, Inc. | $45,178 | 56 | $0 (2024) |
| ALK-Abello, Inc | $24,238 | 34 | $0 (2020) |
| Genentech USA, Inc. | $13,533 | 55 | $0 (2024) |
| Amgen Inc. | $10,978 | 15 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $5,628 | 2 | $0 (2024) |
| Greer Laboratories, Inc. | $4,801 | 6 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $90,387 | 112 | GlaxoSmithKline, LLC. ($34,176) |
| 2023 | $92,212 | 177 | GlaxoSmithKline, LLC. ($52,166) |
| 2022 | $133,429 | 147 | GlaxoSmithKline, LLC. ($72,171) |
| 2021 | $108,854 | 114 | GlaxoSmithKline, LLC. ($34,472) |
| 2020 | $47,153 | 65 | GlaxoSmithKline, LLC. ($8,955) |
| 2019 | $106,113 | 118 | Regeneron Healthcare Solutions, Inc. ($60,738) |
| 2018 | $20,726 | 85 | Regeneron Healthcare Solutions, Inc. ($9,229) |
| 2017 | $14,192 | 25 | ALK-Abello, Inc ($8,014) |
All Payment Transactions
843 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,400.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $3,752.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/06/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $1,876.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $6.95 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.74 | General |
| Category: Immunology | ||||||
| 11/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.01 | General |
| Category: Immunology | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Consulting Fee | Cash or cash equivalent | $2,148.00 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $1,664.00 | General |
| 10/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $11,725.00 | General |
| Category: Immunology | ||||||
| 10/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Travel and Lodging | In-kind items and services | $538.01 | General |
| Category: Immunology | ||||||
| 10/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Travel and Lodging | In-kind items and services | $468.95 | General |
| Category: Immunology | ||||||
| 10/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Travel and Lodging | In-kind items and services | $345.49 | General |
| Category: Immunology | ||||||
| 10/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $124.40 | General |
| Category: Immunology | ||||||
| 10/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Travel and Lodging | In-kind items and services | $562.58 | General |
| Category: Respiratory | ||||||
| 10/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Travel and Lodging | In-kind items and services | $441.35 | General |
| Category: Respiratory | ||||||
| 10/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $123.80 | General |
| Category: Respiratory | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: Respiratory | ||||||
| 09/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $131.45 | General |
| Category: Immunology | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $106.90 | General |
| Category: Respiratory | ||||||
| 09/13/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | CSL Behring | Berinert (Biological) | Education | In-kind items and services | $60.73 | General |
| Category: Immunology | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.98 | General |
| Category: PAIN | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PhIII RANDOMIZED TRIAL OF OMALIZUMAB IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS and PH3 RANDOMIZED MULTICENTER DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF OMALIZUMAB FOR NASAL POLYPS | F. Hoffmann-La Roche AG | $3,147 | 1 |
| A RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP PHASE III STUDY TO ASSESS T | GlaxoSmithKline, LLC. | $1,718 | 7 |
| A RANDOMISED PHIII STUDY TO ASSESS THE EFFECT OF 100 MG SC MEPOLIZUMAB | GlaxoSmithKline, LLC. | $992.39 | 8 |
| A PHASE III, RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF OMALIZUMAB IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, A PHASE III, RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF OMALIZUMAB IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS | F. Hoffmann-La Roche AG | $619.29 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 236 | 1,450 | $85,970 | $22,498 |
| 2022 | 8 | 242 | 2,129 | $79,788 | $18,883 |
| 2021 | 10 | 329 | 3,445 | $130,391 | $36,771 |
| 2020 | 11 | 360 | 3,279 | $110,262 | $27,781 |
Total Patients
1,167
Total Services
10,303
Medicare Billing
$105,932
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 53 | 985 | $34,105 | $9,236 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 96 | $23,814 | $6,241 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $9,334 | $2,548 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 40 | $6,630 | $1,879 | 28.3% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 23 | 156 | $5,460 | $1,130 | 20.7% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 17 | 131 | $3,799 | $767.80 | 20.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,828 | $696.74 | 24.6% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 61 | 850 | $29,750 | $8,174 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 65 | $15,775 | $3,951 | 25.0% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 19 | 797 | $11,955 | $1,871 | 15.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 28 | $4,656 | $1,147 | 24.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $4,384 | $1,066 | 24.3% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 21 | 148 | $5,180 | $945.73 | 18.3% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2022 | 17 | 82 | $3,854 | $865.61 | 22.5% |
| 95115 | Professional service for single injection of allergen | Office | 2022 | 36 | 146 | $4,234 | $862.77 | 20.4% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 69 | 1,336 | $42,730 | $14,591 | 34.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 67 | 88 | $19,340 | $6,189 | 32.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $10,051 | $2,746 | 27.3% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 21 | 889 | $13,335 | $2,591 | 19.4% |
| 95024 | Injection of allergenic extracts into skin for immediate reaction analysis | Office | 2021 | 12 | 386 | $7,334 | $2,262 | 30.8% |
| 95012 | Measurement of inhaled nitric oxide gas | Office | 2021 | 21 | 145 | $6,815 | $1,830 | 26.8% |
| 95115 | Injection of incremental dosages of allergen | Office | 2021 | 36 | 285 | $8,077 | $1,640 | 20.3% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 22 | 224 | $7,840 | $1,606 | 20.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 26 | $4,008 | $1,304 | 32.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 14 | 17 | $1,809 | $1,177 | 65.1% |
About Dr. Christine Franzese, M.D
Dr. Christine Franzese, M.D is a Otolaryngology healthcare provider based in Columbia, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932171352.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christine Franzese, M.D has received a total of $613,066 in payments from pharmaceutical and medical device companies, with $90,387 received in 2024. These payments were reported across 843 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($415,999).
As a Medicare-enrolled provider, Franzese has provided services to 1,167 Medicare beneficiaries, totaling 10,303 services with total Medicare billing of $105,932. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Otolaryngology
- Other Specialties Otolaryngic Allergy
- Location Columbia, MO
- Active Since 02/02/2006
- Last Updated 04/10/2024
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1932171352
Products in Payments
- NUCALA (Biological) $204,500
- DUPIXENT (Biological) $163,048
- FASENRA (Biological) $53,508
- Xhance (Drug) $45,178
- TEZSPIRE (Biological) $30,949
- Xolair (Biological) $22,609
- DUPIXENT (Drug) $16,175
- FASENRA (Drug) $16,111
- Odactra (Drug) $14,644
- DUPIXENT DUPILUMAB INJECTION (Biological) $9,229
- Grastek (Biological) $4,250
- Odactra (Biological) $3,750
- MK-7264 (Drug) $2,011
- Dust mite (D. farinae) (Biological) $1,580
- PANZYGA (Biological) $1,110
- VIVAER STYLUS (Device) $408.12
- HYQVIA (Biological) $279.40
- PROPEL (Device) $242.37
- Xembify (Biological) $241.13
- CUVITRU (Biological) $227.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Columbia
Dr. John Rich, Md, MD
Otolaryngology — Payments: $28,614
Otolaryngology $28,614
Dr. Jonathon Russell, Md, MD
Otolaryngology — Payments: $18,942
Otolaryngology $18,942
Arnaldo Rivera Perez, M.d, M.D
Otolaryngology — Payments: $18,008
Otolaryngology $18,008
Mr. Stephen Parey, Md, MD
Otolaryngology — Payments: $4,050
Otolaryngology $4,050
Dr. Ira Uretzky, Md, MD
Otolaryngology — Payments: $3,246
Otolaryngology $3,246
Ketan Shah, M.d, M.D
Otolaryngology — Payments: $2,952
Otolaryngology $2,952